QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.068429v1 311/1/213    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Piper, J. L. Articles by Khosla, C. Search for Related Content PubMed PubMed Citation Articles by Piper, J. L. Articles by Khosla, C.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Effect of Prolyl Endopeptidase on Digestive-Resistant Gliadin Peptides in Vivo

Departments of Chemistry (C.K.), Chemical Engineering (J.L.P., C.K.), and Medicine (G.M.G.), Stanford University, Stanford, California

Many gluten peptides elicit proliferative responses from T cells from Celiac Sprue patients, influencing the pathogenesis of this small intestinal disorder. These peptides are Pro- and Gln-rich in character, suggesting that resistance to proteolysis promotes their toxicity. To test this hypothesis, we analyzed the digestive resistance of a panel of - and -gliadin peptides believed to induce toxicity via diverse mechanisms. Most were highly resistant to gastric and pancreatic protease digestion, but they were digested by intestinal brush-border peptidases. In some instances, there was accumulation of relatively long intermediates. Control peptides from gliadin and myoglobin revealed that digestive resistance depended on factors other than size. Prolyl endopeptidase (PEP) supplementation substantially reduced the concentrations of these peptides. To estimate a pharmacologically useful PEP dose, recombinant PEP was coperfused into rat intestine with the highly digestive-resistant 33-mer peptide LQLQPF(PQPQLPY)₃ PQPQPF (PEP: peptide weight ratio 1:50 to 1:5). PEP dosing experiments indicate significant changes in the average residence time. The in vivo benefit of PEP was verified by coperfusion with a mixture of 33-mer and partially proteolyzed gliadin. These data verify and extend our earlier proposal that gliadin peptides, although resistant to proteolysis, can be processed efficiently by PEP supplementation. Indeed, PEP may be able to treat Celiac Sprue by reducing or eliminating such peptides from the intestine.

Address correspondence to: Dr. C. Khosla, Departments of Chemistry and Chemical Engineering, 380 Roth Way, Keck Science Bldg., Rm. 389, Stanford, CA 94305-5025. E-mail: ck{at}chemeng.stanford.edu

This article has been cited by other articles:

				J. Ehren, S. Govindarajan, B. Moron, J. Minshull, and C. Khosla Protein engineering of improved prolyl endopeptidases for celiac sprue therapy Protein Eng. Des. Sel., December 1, 2008; 21(12): 699 - 707. [Abstract] [Full Text] [PDF]

				C Mitea, R Havenaar, J W. Drijfhout, L Edens, L Dekking, and F Koning Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease Gut, January 1, 2008; 57(1): 25 - 32. [Abstract] [Full Text] [PDF]

				C. G. Rizzello, M. De Angelis, R. Di Cagno, A. Camarca, M. Silano, I. Losito, M. De Vincenzi, M. D. De Bari, F. Palmisano, F. Maurano, et al. Highly Efficient Gluten Degradation by Lactobacilli and Fungal Proteases during Food Processing: New Perspectives for Celiac Disease Appl. Envir. Microbiol., July 15, 2007; 73(14): 4499 - 4507. [Abstract] [Full Text] [PDF]

				D. Stepniak, L. Spaenij-Dekking, C. Mitea, M. Moester, A. de Ru, R. Baak-Pablo, P. van Veelen, L. Edens, and F. Koning Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G621 - G629. [Abstract] [Full Text] [PDF]

				J. Gass, H. Vora, M. T. Bethune, G. M. Gray, and C. Khosla Effect of Barley Endoprotease EP-B2 on Gluten Digestion in the Intact Rat J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1178 - 1186. [Abstract] [Full Text] [PDF]

				T. Marti, O. Molberg, Q. Li, G. M. Gray, C. Khosla, and L. M. Sollid Prolyl Endopeptidase-Mediated Destruction of T Cell Epitopes in Whole Gluten: Chemical and Immunological Characterization J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 19 - 26. [Abstract] [Full Text] [PDF]